Home › Stock analysis › LUCD
Lucid Diagnostics (LUCD) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
What changed since yesterday
- Closed at $0.48, -8.08% vs the prior close of $0.52.
- Volume 2.33M shares, 1.8x its 50-day average.
- New SEC filings: 8-K (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
LUCD slides 8.1% to $0.48, a 52-week low, 3 down days in a row. Closed at $0.48, -8.08% vs the prior close of $0.52. Day range $0.47–$0.53, opened at $0.52.
Last close$0.48-8.08%
Day range0.47–0.53
Open0.52
Volume2.33M
52-week range0.47–1.63
Avg volume (20d)1.89M
LUCD daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — LUCD slides 8.1% to $0.48, a 52-week low, 3 down days in a row
- Closed at $0.48, -8.08% vs the prior close of $0.52. Day range $0.47–$0.53, opened at $0.52.
- Volume was 2.33M shares, 1.8x its 50-day average of 1.31M.
- Price is -42.4% vs its 50-day average ($0.83) and -55.0% vs its 200-day average ($1.06).
- 52-week range $0.47–$1.63; today's close sits at 1% of that range, 70.7% below the 52-week high.
- That makes 3 straight losses.
Oct 15, 2026 — LUCD slides 4.2% to $0.52, a 52-week low on 2.3x normal volume
- Closed at $0.52, -4.24% vs the prior close of $0.54. Day range $0.51–$0.57, opened at $0.54.
- Volume was 3.01M shares, 2.3x its 50-day average of 1.30M — unusually heavy trading.
- Price is -38.1% vs its 50-day average ($0.84) and -51.2% vs its 200-day average ($1.07).
- 52-week range $0.50–$1.63; today's close sits at 2% of that range, 68.1% below the 52-week high.
Oct 14, 2026 — LUCD slides 10.4% to $0.54, a 52-week low
- Closed at $0.54, -10.40% vs the prior close of $0.61. Day range $0.54–$0.62, opened at $0.59.
- Volume was 1.82M shares, 1.4x its 50-day average of 1.29M.
- Price is -36.0% vs its 50-day average ($0.85) and -49.2% vs its 200-day average ($1.07).
- 52-week range $0.50–$1.63; today's close sits at 4% of that range, 66.7% below the 52-week high.
Oct 13, 2026 — LUCD rises 1.5% to $0.61
- Closed at $0.61, +1.51% vs the prior close of $0.60. Day range $0.58–$0.62, opened at $0.60.
- Volume was 1.10M shares, 0.8x its 50-day average of 1.29M.
- Price is -29.3% vs its 50-day average ($0.86) and -43.4% vs its 200-day average ($1.07).
- 52-week range $0.50–$1.63; today's close sits at 9% of that range, 62.8% below the 52-week high.
Oct 12, 2026 — LUCD slides 6.4% to $0.60
- Closed at $0.60, -6.43% vs the prior close of $0.64. Day range $0.60–$0.66, opened at $0.63.
- Volume was 1.64M shares, 1.3x its 50-day average of 1.28M.
- Price is -31.0% vs its 50-day average ($0.86) and -44.4% vs its 200-day average ($1.07).
- 52-week range $0.50–$1.63; today's close sits at 9% of that range, 63.4% below the 52-week high.
Oct 9, 2026 — LUCD dips 1.8% to $0.64
- Closed at $0.64, -1.85% vs the prior close of $0.65. Day range $0.62–$0.69, opened at $0.65.
- Volume was 1.95M shares, 1.5x its 50-day average of 1.26M.
- Price is -26.7% vs its 50-day average ($0.87) and -40.7% vs its 200-day average ($1.08).
- 52-week range $0.50–$1.63; today's close sits at 12% of that range, 60.8% below the 52-week high.
Oct 8, 2026 — LUCD jumps 4.2% to $0.65 on 2.0x normal volume
- Closed at $0.65, +4.17% vs the prior close of $0.62. Day range $0.60–$0.67, opened at $0.61.
- Volume was 2.51M shares, 2.0x its 50-day average of 1.23M — unusually heavy trading.
- Price is -25.7% vs its 50-day average ($0.88) and -39.7% vs its 200-day average ($1.08).
- 52-week range $0.50–$1.63; today's close sits at 13% of that range, 60.1% below the 52-week high.
- That makes 3 straight gains.
Oct 7, 2026 — LUCD jumps 4.0% to $0.62
- Closed at $0.62, +4.00% vs the prior close of $0.60. Day range $0.59–$0.65, opened at $0.59.
- Volume was 1.71M shares, 1.4x its 50-day average of 1.21M.
- Price is -29.2% vs its 50-day average ($0.88) and -42.2% vs its 200-day average ($1.08).
- 52-week range $0.50–$1.63; today's close sits at 11% of that range, 61.7% below the 52-week high.
Oct 6, 2026 — LUCD rises 1.2% to $0.60
- Closed at $0.60, +1.18% vs the prior close of $0.59. Day range $0.58–$0.61, opened at $0.60.
- Volume was 1.46M shares, 1.2x its 50-day average of 1.21M.
- Price is -32.3% vs its 50-day average ($0.89) and -44.6% vs its 200-day average ($1.08).
- 52-week range $0.50–$1.63; today's close sits at 9% of that range, 63.2% below the 52-week high.
Oct 5, 2026 — LUCD slides 5.4% to $0.59, a 52-week low, 4 down days in a row
- Closed at $0.59, -5.42% vs the prior close of $0.63. Day range $0.59–$0.68, opened at $0.62.
- Volume was 1.83M shares, 1.5x its 50-day average of 1.21M.
- Price is -33.6% vs its 50-day average ($0.89) and -45.4% vs its 200-day average ($1.09).
- 52-week range $0.50–$1.63; today's close sits at 8% of that range, 63.6% below the 52-week high.
- That makes 4 straight losses.
Oct 2, 2026 — LUCD dips 1.3% to $0.63, a 52-week low on 1.9x normal volume
- Closed at $0.63, -1.26% vs the prior close of $0.63. Day range $0.62–$0.68, opened at $0.63.
- Volume was 2.26M shares, 1.9x its 50-day average of 1.18M — unusually heavy trading.
- Price is -30.3% vs its 50-day average ($0.90) and -42.4% vs its 200-day average ($1.09).
- 52-week range $0.50–$1.63; today's close sits at 11% of that range, 61.5% below the 52-week high.
- That makes 3 straight losses.
LUCD latest news & SEC filings
Every SEC filing by or about LUCD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Sep 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$11.69M (prior year -$4.44M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.08 (prior year -$0.08) ( vs Jun 30, 2025)
Jun 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade LUCD
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 26, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.74% (largest 15.4%). That is a volatile stock.
- Liquidity: about 1.89M shares (≈$905.34K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.48 vs a range of $0.47–$1.63 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 0 sales; latest: Dennis Matheis bought 245,000 shares on May 20, 2026.
- Latest filings: 8-K Oct 16, 2026; 8-K Sep 22, 2026; 8-K Aug 13, 2026.
- Share count: 203.24M shares outstanding (Aug 10, 2026), +87.5% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
LUCD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.52 | 0.53 | 0.47 | 0.48 | 2.33M |
| Oct 15, 2026 | 0.54 | 0.57 | 0.51 | 0.52 | 3.01M |
| Oct 14, 2026 | 0.59 | 0.62 | 0.54 | 0.54 | 1.82M |
| Oct 13, 2026 | 0.60 | 0.62 | 0.58 | 0.61 | 1.10M |
| Oct 12, 2026 | 0.63 | 0.66 | 0.60 | 0.60 | 1.64M |
| Oct 9, 2026 | 0.65 | 0.69 | 0.62 | 0.64 | 1.95M |
| Oct 8, 2026 | 0.61 | 0.67 | 0.60 | 0.65 | 2.51M |
| Oct 7, 2026 | 0.59 | 0.65 | 0.59 | 0.62 | 1.71M |
| Oct 6, 2026 | 0.60 | 0.61 | 0.58 | 0.60 | 1.46M |
| Oct 5, 2026 | 0.62 | 0.68 | 0.59 | 0.59 | 1.83M |
| Oct 2, 2026 | 0.63 | 0.68 | 0.62 | 0.63 | 2.26M |
| Oct 1, 2026 | 0.72 | 0.73 | 0.50 | 0.63 | 6.78M |
| Sep 30, 2026 | 0.81 | 0.81 | 0.74 | 0.75 | 1.77M |
| Sep 29, 2026 | 0.81 | 0.83 | 0.80 | 0.81 | 763.10K |
| Sep 28, 2026 | 0.82 | 0.83 | 0.80 | 0.81 | 781.60K |
| Sep 25, 2026 | 0.84 | 0.85 | 0.82 | 0.83 | 1.19M |
| Sep 24, 2026 | 0.83 | 0.88 | 0.82 | 0.84 | 1.13M |
| Sep 23, 2026 | 0.88 | 0.90 | 0.82 | 0.84 | 939.60K |
| Sep 22, 2026 | 0.86 | 0.91 | 0.83 | 0.89 | 1.53M |
| Sep 21, 2026 | 0.79 | 0.85 | 0.77 | 0.85 | 1.39M |
About Lucid Diagnostics
Lucid Diagnostics (LUCD) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1799011.
LUCD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Lishan Aklog | Chief Executive Officer | Feb 24, 2026 |
| James L Cox | Director | Feb 24, 2026 |
| Stanley Lapidus | Director | Feb 24, 2026 |
| Dennis Matheis | Director | May 21, 2026 |
| John R Palumbo | Director | Feb 24, 2026 |
| Jacque J Sokolov | Director | Feb 24, 2026 |
| Ronald M Sparks | Director | Feb 24, 2026 |
| Debra White | Director | Feb 24, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Lishan Aklog | Chief Executive Officer | Feb 24, 2026 |
| Michael Adam Gordon | General Counsel and Secretary | Feb 24, 2026 |
| Victoria Tou-Ho Lee | Chief Medical Officer | Apr 24, 2026 |
| Dennis M Mcgrath | Chief Financial Officer | Feb 24, 2026 |
| Shaun O'Neil | President and COO | Feb 24, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 20, 2026 | Dennis Matheis | Buy | 245,000 | $1.00 |
| May 20, 2026 | Dennis Matheis | Buy | 245,000 | $1.00 |
| May 20, 2026 | Dennis Matheis | Buy | 245,000 | $1.00 |
| May 20, 2026 | Dennis Matheis | Buy | 245,000 | $1.00 |
LUCD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-58.01M | — | $-46.48M |
| Dec 31, 2024 | $4.35M | $-45.53M | -1.05 | $-44.14M |
| Dec 31, 2023 | $2.43M | $-52.67M | -1.26 | $-32.82M |
| Dec 31, 2022 | $377.00K | $-56.17M | -1.55 | $-29.68M |
| Dec 31, 2021 | $500.00K | $-28.08M | — | $-17.67M |
Latest balance sheet: total assets $38.95M, total liabilities $28.02M, cash $47.33M (as of Jun 30, 2026).
LUCD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $0.96 |
| May 14, 2026 | 8-K Item 2.02 (results) | $1.02 |
| Mar 26, 2026 | 8-K Item 2.02 (results) | $1.15 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $1.11 |
| Aug 13, 2025 | 8-K Item 2.02 (results) | $0.98 |
| May 14, 2025 | 8-K Item 2.02 (results) | $1.28 |
| Mar 25, 2025 | 8-K Item 2.02 (results) | $1.55 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $1.05 |
| Aug 12, 2024 | 8-K Item 2.02 (results) | — |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| Nov 14, 2023 | 8-K Item 2.02 (results) | — |
| Mar 14, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on LUCD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.